This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

Ingo Gorr
Head of Therapeutic Virus Development at Boehringer Ingelheim


Ingo Gorr received his Biology degree from the University of Wuerzburg in Germany, followed by a PhD in the Molecular Cell Biology department at the Max-Planck-Institute of Biochemistry in Martinsried/Germany. He then joined Roche first in Basel/Switzerland and later in Penzberg/Germany working in cell culture research. In 2015 he transitioned to Boehringer Ingelheim in Biberach/Germany and held leadership positions in upstream and downstream bioprocess development as well as in analytical development and QC before he became the head of therapeutic virus development.

Agenda Sessions

  • Keynote Address: Unveiling success factors in developing a scalable manufacturing process for an oncolytic virus.